Clinical trials, including TRIUMPH-2 and TRIUMPH-3, continue, exploring overweight adults with conditions like type 2 diabetes and cardiovascular outcomes
A useful review verifies prescriber licensure, names or confirms the pharmacy pathway, notes whether contraindication screening happens, and shows real pricing
This multi-pronged mechanism produces meaningful weight loss in many patients
However, their use requires careful monitoring, with potential side effects including urinary tract infections, dehydration, and rare cases of diabetic ketoacidosis or bone fractures
An oral alternative to weekly injections could dramatically expand the addressable market and create barriers to entry for competitors still stuck in the injectable paradigm
Rushing to higher doses increases gastrointestinal side effects without meaningfully accelerating weight loss